TEVA insider buying and SEC filings, explained
Teva Pharmaceutical Industries Ltd. · CIK 818686
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- NYSE
- Industry (SIC)
- Pharmaceutical Preparations
- State of incorporation
- L3
- Fiscal year end
- Dec 31
- Former names
- TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$40.6M
Planned sales (10b5-1)
$69.2M
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Sep 18, 2026 | Sale | Brian Savage (Interim Chief Legal Officer) sold 7,342 shares at about $38.85 ($285K). Holdings down 46% to 8,500 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 22, 2026 |
| Sep 18, 2026 | Sale | Roberto Mignone (Director) sold 367,600 shares indirectly at about $39.06 ($14.4M). Indirect holdings down 100% to 0 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 22, 2026 |
| Aug 21, 2026 | Sale | Amir Weiss (Chief Accounting Officer) sold 9,445 shares at about $37.62 ($355K). Holdings down 42% to 13,071 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 25, 2026 |
| Aug 21, 2026 | Sale | Ronit Satchi-Fainaro (Director) sold 415 shares at $37.25 ($15K). Holdings down <1% to 111,986 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 25, 2026 |
| Aug 17, 2026 | Planned (10b5-1) | Evan Lippman (EVP, Business Development) sold 18,600 shares at about $36.57 ($680K), marked as a 10b5-1 plan trade. Holdings down 42% to 25,591 shares. | SEC filing Filed Aug 19, 2026 |
| Aug 5, 2026 | Sale | Tal Zvi Zaks (Director) sold 17 shares at $34.87 ($593). Holdings down <1% to 73,247 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 10, 2026 |
| Aug 3, 2026 | Planned (10b5-1) | Placid Jover (See "Remarks") sold 12,827 shares at about $34.88 ($447K), marked as a 10b5-1 plan trade. Holdings down 65% to 6,774 shares. | SEC filing Filed Aug 5, 2026 |
| Aug 3, 2026 | Planned (10b5-1) | Eric A Hughes (See "Remarks") sold 25,578 shares at about $34.88 ($892K), marked as a 10b5-1 plan trade. Holdings down 16% to 134,877 shares. | SEC filing Filed Aug 5, 2026 |
| Jun 18, 2026 | Sale | Matthew Shields (EVP, Global Operations) sold 9,989 shares at $32.19 ($322K). Holdings down 100% to 0 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 22, 2026 |
| Jun 11, 2026 | Planned (10b5-1) | Eliyahu Sharon Kalif (CFO) sold 106,563 shares at about $34.10 ($3.6M), marked as a 10b5-1 plan trade. Holdings down 62% to 65,621 shares. | SEC filing Filed Jun 16, 2026 |
| Jun 5, 2026 | Planned (10b5-1) | Richard D Francis (CEO) sold 6,153 shares at $34.35 ($211K), marked as a 10b5-1 plan trade. Holdings down 1% to 1,177,529 shares. | SEC filing Filed Jun 8, 2026 |
| Jun 3, 2026 | Planned (10b5-1) | Matthew Shields (EVP, Global Operations) sold 16,195 shares at $32.87 ($532K), marked as a 10b5-1 plan trade. Holdings down 62% to 9,989 shares. | SEC filing Filed Jun 4, 2026 |
| May 14, 2026 | Planned (10b5-1) | Evan Lippman (EVP, Business Development) sold 41,658 shares at about $35.58 ($1.5M), marked as a 10b5-1 plan trade. Holdings down 49% to 44,191 shares. | SEC filing Filed May 18, 2026 |
| May 14, 2026 | Planned (10b5-1) | Eliyahu Sharon Kalif (CFO) sold 153,251 shares at about $35.61 ($5.5M), marked as a 10b5-1 plan trade. Holdings down 47% to 172,184 shares. | SEC filing Filed May 18, 2026 |
| May 6, 2026 | Sale | Amir Weiss (Chief Accounting Officer) sold 10,679 shares at $36.00 ($384K). Holdings down 35% to 20,016 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 7, 2026 |
| May 5, 2026 | Sale | Richard Daniell (EVP, Europe Commercial) sold 30,000 shares at $35.40 ($1.1M). Holdings down 35% to 55,755 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 7, 2026 |
| May 1, 2026 | Sale | Mark Sabag (See "Remarks") sold 144,180 shares at about $34.99 ($5.0M). Holdings down 64% to 80,760 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 4, 2026 |
| Apr 30, 2026 | Sale | Christine Fox (EVP, U.S. Commercial) sold 21,258 shares at about $35.31 ($751K). Holdings down 25% to 63,647 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 4, 2026 |
| Mar 17, 2026 | Sale | Mark Sabag (See "Remarks") sold 62,102 shares at about $30.14 ($1.9M). Holdings down 22% to 224,940 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 19, 2026 |
| Mar 5, 2026 | Planned (10b5-1) | Richard D Francis (CEO) sold 20,025 shares at about $31.67 ($634K), marked as a 10b5-1 plan trade. Holdings down 2% to 1,170,639 shares. | SEC filing Filed Mar 9, 2026 |
| Mar 5, 2026 | Planned (10b5-1) | Christine Fox (EVP, U.S. Commercial) sold 7,924 shares at about $31.67 ($251K), marked as a 10b5-1 plan trade. Holdings down 9% to 84,905 shares. | SEC filing Filed Mar 9, 2026 |
| Mar 5, 2026 | Planned (10b5-1) | Eric A Hughes (See "Remarks") sold 9,533 shares at about $31.67 ($302K), marked as a 10b5-1 plan trade. Holdings down 8% to 107,711 shares. | SEC filing Filed Mar 9, 2026 |
| Mar 5, 2026 | Planned (10b5-1) | Richard Daniell (EVP, Europe Commercial) sold 17,295 shares at about $31.67 ($548K), marked as a 10b5-1 plan trade. Holdings down 17% to 85,755 shares. | SEC filing Filed Mar 9, 2026 |
| Mar 5, 2026 | Planned (10b5-1) | Placid Jover (See "Remarks") sold 14,150 shares at about $31.67 ($448K), marked as a 10b5-1 plan trade. Holdings down 68% to 6,774 shares. | SEC filing Filed Mar 9, 2026 |
| Mar 5, 2026 | Planned (10b5-1) | Matthew Shields (EVP, Global Operations) sold 17,295 shares at about $31.67 ($548K), marked as a 10b5-1 plan trade. Holdings down 63% to 9,989 shares. | SEC filing Filed Mar 9, 2026 |
| Mar 4, 2026 | Planned (10b5-1) | Richard D Francis (CEO) sold 23,393 shares at about $32.46 ($759K), marked as a 10b5-1 plan trade. Holdings down 2% to 1,148,212 shares. | SEC filing Filed Mar 6, 2026 |
| Mar 4, 2026 | Planned (10b5-1) | Richard Daniell (EVP, Europe Commercial) sold 91,345 shares at about $32.66 ($3.0M), marked as a 10b5-1 plan trade. Holdings down 52% to 85,755 shares. | SEC filing Filed Mar 6, 2026 |
| Mar 4, 2026 | Planned (10b5-1) | Eric A Hughes (See "Remarks") sold 11,277 shares at about $32.46 ($366K), marked as a 10b5-1 plan trade. Holdings down 10% to 97,590 shares. | SEC filing Filed Mar 6, 2026 |
| Mar 4, 2026 | Planned (10b5-1) | Christine Fox (EVP, U.S. Commercial) sold 9,098 shares at about $32.46 ($295K), marked as a 10b5-1 plan trade. Holdings down 11% to 75,010 shares. | SEC filing Filed Mar 6, 2026 |
| Mar 3, 2026 | Planned (10b5-1) | Richard Daniell (EVP, Europe Commercial) sold 128,985 shares at about $32.36 ($4.2M), marked as a 10b5-1 plan trade. Holdings down 51% to 123,127 shares. | SEC filing Filed Mar 5, 2026 |
| Mar 3, 2026 | Planned (10b5-1) | Richard D Francis (CEO) sold 442,935 shares at about $32.36 ($14.3M), marked as a 10b5-1 plan trade. Holdings down 28% to 1,121,382 shares. | SEC filing Filed Mar 5, 2026 |
| Mar 3, 2026 | Planned (10b5-1) | Eric A Hughes (See "Remarks") sold 80,762 shares at about $32.36 ($2.6M), marked as a 10b5-1 plan trade. Holdings down 49% to 85,616 shares. | SEC filing Filed Mar 5, 2026 |
| Feb 26, 2026 | Planned (10b5-1) | Eliyahu Sharon Kalif (CFO) sold 345,810 shares at about $33.64 ($11.6M), marked as a 10b5-1 plan trade. Holdings down 86% to 57,478 shares. | SEC filing Filed Mar 2, 2026 |
| Feb 15, 2026 | Planned (10b5-1) | Richard D Francis (CEO) sold 447,778 shares at about $34.22 ($15.3M), marked as a 10b5-1 plan trade. Holdings down 43% to 605,771 shares. | SEC filing Filed Feb 18, 2026 |
| Dec 16, 2025 | Sale | Amir Weiss (Chief Accounting Officer) sold 12,300 shares at about $30.20 ($371K). Holdings down 69% to 5,650 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 18, 2025 |
| Dec 16, 2025 | Sale | Roberto Mignone (Director) sold 77,400 shares indirectly at about $30.24 ($2.3M). Indirect holdings down 17% to 367,600 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 18, 2025 |
| Dec 9, 2025 | Sale | Mark Sabag (See "Remarks") sold 216,892 shares at about $28.73 ($6.2M). Holdings down 80% to 52,828 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 11, 2025 |
| Nov 26, 2025 | Sale | Roberto Mignone (Director) sold 50,000 shares indirectly at about $26.03 ($1.3M). Indirect holdings down 10% to 445,000 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 1, 2025 |
| Nov 20, 2025 | Planned (10b5-1) | Christine Fox (EVP, Head of U.S. Commercial) sold 28,229 shares at $24.78 ($700K), marked as a 10b5-1 plan trade. Holdings down 31% to 63,647 shares. | SEC filing Filed Nov 24, 2025 |
| Nov 14, 2025 | Sale | Christine Fox (EVP, Head of U.S. Commercial) sold 30,000 shares at $25.11 ($753K). Holdings down 51% to 28,384 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 18, 2025 |
| Nov 6, 2025 | Sale | Roberto Mignone (Director) sold 200,000 shares indirectly at about $24.11 ($4.8M). Indirect holdings down 29% to 495,000 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 10, 2025 |
| Nov 6, 2025 | Sale | Amir Weiss (Chief Accounting Officer) sold 12,300 shares at about $24.44 ($301K). Holdings down 41% to 17,950 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 10, 2025 |
67 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
| Filed | Items | Tag | Source |
|---|---|---|---|
| Nov 3, 2026, 8:08 AM ET 8-K | Earnings released (Item 2.02) | SEC filing | |
| Oct 29, 2026, 5:08 PM ET 8-K | Executive or director change (Item 5.02) | SEC filing |
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow TEVA in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.